{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,10]],"date-time":"2026-06-10T13:04:03Z","timestamp":1781096643933,"version":"3.54.1"},"reference-count":23,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,1,1]],"date-time":"2018-01-01T00:00:00Z","timestamp":1514764800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2017,12,14]],"date-time":"2017-12-14T00:00:00Z","timestamp":1513209600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/3.0\/igo\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.fr","clinicalkey.com.au","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2018,1]]},"DOI":"10.1016\/j.vaccine.2017.10.065","type":"journal-article","created":{"date-parts":[[2018,1,4]],"date-time":"2018-01-04T15:20:54Z","timestamp":1515079254000},"page":"A35-A42","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":73,"special_numbering":"S1","title":["Measles and Rubella Global Strategic Plan 2012\u20132020 midterm review report: Background and summary"],"prefix":"10.1016","volume":"36","author":[{"given":"Walter A.","family":"Orenstein","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lisa","family":"Cairns","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alan","family":"Hinman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Benjamin","family":"Nkowane","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean-Marc","family":"Oliv\u00e9","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arthur L.","family":"Reingold","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2017.10.065_b0005","series-title":"Measles vaccines","article-title":"Plotkin\u2019s vaccines","author":"Strebel","year":"2018"},{"key":"10.1016\/j.vaccine.2017.10.065_b0010","doi-asserted-by":"crossref","unstructured":"Orenstein WA, Gay NJ. The theory of measles elimination: implications for the design of elimination strategies. J Infect Dis [Internet] 2004;189(S1):S27\u201335. Available from: <https:\/\/academic.oup.com\/jid\/article-lookup\/doi\/10.1086\/381592> [cited 2017 Mar 5].","DOI":"10.1086\/381592"},{"key":"10.1016\/j.vaccine.2017.10.065_b0015","doi-asserted-by":"crossref","unstructured":"Patel MK, Gacic-Dobo M, Strebel PM, Dabbagh A, Mulders MN, Okwo-Bele J-M, et al. Progress toward regional measles elimination \u2014 worldwide, 2000\u20132015. Morb Mortal Wkly Rep [Internet]. 2016 Nov 11 [cited 2017 Apr 13];65(44):1228\u20133. Available from: http:\/\/www.cdc.gov\/mmwr\/volumes\/65\/wr\/mm6544a6.htm.","DOI":"10.15585\/mmwr.mm6544a6"},{"key":"10.1016\/j.vaccine.2017.10.065_b0020","unstructured":"Health systems goal indicators - Gavi, the Vaccine Alliance [Internet]. [cited 2017 Mar 5]. Available from: http:\/\/www.gavi.org\/results\/goal-level-indicators\/health-systems-goal-indicators\/."},{"issue":"1","key":"10.1016\/j.vaccine.2017.10.065_b0025","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1007\/BF01531116","article-title":"Follow-up report on autism in congenital rubella","volume":"7","author":"Chess","year":"1977","journal-title":"J. Autism Child Schizophr"},{"key":"10.1016\/j.vaccine.2017.10.065_b0030","doi-asserted-by":"crossref","unstructured":"Vynnycky E, Adams EJ, Cutts FT, Reef SE, Navar AM, Simons E, et al. Using seroprevalence and immunisation coverage data to estimate the global burden of congenital rubella syndrome, 1996-2010: a systematic review. PLoS One [Internet]. 2016 [cited 2017 Mar 5];11(3):e0149160. Available from: https:\/\/plos.org\/10.1371\/journal.pone.0149160.","DOI":"10.1371\/journal.pone.0149160"},{"key":"10.1016\/j.vaccine.2017.10.065_b0035","unstructured":"WHO. Meeting of the Strategic Group of Experts on Immunization, November 2010 \u2013 summary, conclusions and recommendations. Wkly Epidemiol Rec [Internet]. 2011 [cited 2017 Mar 5];86(1\/2):1\u201316. Available from: http:\/\/www.who.int\/wer\/2011\/wer8601_02\/en\/."},{"key":"10.1016\/j.vaccine.2017.10.065_b0040","doi-asserted-by":"crossref","unstructured":"WHO. Proceedings of the Global Technical Consultation to Assess the Feasibility of Measles Eradication, 28\u201330 July 2010. J Infect Dis [Internet]. 2011 [cited 2017 Mar 5];204(suppl. 1):S4\u201313. Available from: http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/21666191.","DOI":"10.1093\/infdis\/jir100"},{"key":"10.1016\/j.vaccine.2017.10.065_b0045","unstructured":"WHO. Meeting of the International Task Force for Disease Eradication, November 2015. Wkly Epidemiol Rec [Internet]. 2016 [cited 2017 Mar 5];91(6):61\u201371. Available from: http:\/\/www.who.int\/wer\/2016\/wer9106\/en\/."},{"key":"10.1016\/j.vaccine.2017.10.065_b0050","doi-asserted-by":"crossref","unstructured":"Thompson KM, Badizadegan ND. Modeling the transmission of measles and rubella to support global management policy analyses and eradication investment cases. Risk Anal [Internet]. 2017 Jun 1 [cited 2017 Oct 14];37(6):1109\u201331. Available from: http:\/\/doi.wiley.com\/10.1111\/risa.12831.","DOI":"10.1111\/risa.12831"},{"key":"10.1016\/j.vaccine.2017.10.065_b0055","unstructured":"Global Vaccine Action Plan 2011\u20132020 [Internet]. World Health Organization; 2015 [cited 2017 Mar 5]. Available from: http:\/\/www.who.int\/immunization\/global_vaccine_action_plan\/GVAP_doc_2011_2020\/en\/."},{"key":"10.1016\/j.vaccine.2017.10.065_b0060","unstructured":"WHO. Rubella vaccines: WHO position paper. Wkly Epidemiol Rec [Internet]. 2011 [cited 2017 Mar 8];86(29):301\u201316. Available from: http:\/\/www.who.int\/wer\/2011\/wer8629.pdf?ua=1."},{"key":"10.1016\/j.vaccine.2017.10.065_b0065","unstructured":"WHO. Measles vaccines: WHO position paper \u2013 April 2017. Wkly Epidemiol Rec [Internet]. 2017 [cited 2017 Oct 14];92:205\u201328. Available from: http:\/\/www.who.int\/wer."},{"key":"10.1016\/j.vaccine.2017.10.065_b0070","unstructured":"Vaccines and Biologicals. World Health Organization. WHO\u2013recommended standards for surveillance of selected vaccine-preventable diseases [Internet]. Geneva; 2003 [cited 2017 Mar 8]. Available from: http:\/\/apps.who.int\/iris\/bitstream\/10665\/68334\/1\/WHO_V-B_03.01_eng.pdf?ua=1."},{"key":"10.1016\/j.vaccine.2017.10.065_b0075","unstructured":"WHO. Framework for verifying elimination of measles and rubella. Wkly Epidemiol Rec [Internet]. 2013 [cited 2017 Mar 8];88(9):89\u201399. Available from: http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/23540051."},{"key":"10.1016\/j.vaccine.2017.10.065_b0080","unstructured":"CDC. Recommendations from an Ad Hoc Meeting of the WHO Measles and Rubella Laboratory Network (LabNet) on Use of Alternative Diagnostic Samples for Measles and Rubella Surveillance. Morb Mortal Wkly Rep [Internet]. 2008 [cited 2017 Apr 5];57(24):657\u201360. Available from: https:\/\/www.cdc.gov\/mmwr\/preview\/mmwrhtml\/mm5724a3.htm."},{"key":"10.1016\/j.vaccine.2017.10.065_b0085","unstructured":"WHO. Global Measles and Rubella Strategic Plan 2012-2020 [Internet]. 2012 [cited 2017 Mar 5]. Available from: http:\/\/apps.who.int\/iris\/bitstream\/10665\/44855\/1\/9789241503396_eng.pdf."},{"key":"10.1016\/j.vaccine.2017.10.065_b0090","unstructured":"Gavi\u2019s mission - Gavi, the Vaccine Alliance [Internet]. [cited 2017 Mar 8]. Available from: http:\/\/www.gavi.org\/about\/mission\/."},{"key":"10.1016\/j.vaccine.2017.10.065_b0095","unstructured":"CDC. Progress in Measles Control \u2013 Kenya 2002\u20132007. Morb Mortal Wkly Rep [Internet]. 2007 [cited 2017 Oct 16];56(37):969\u201372. Available from: https:\/\/www.cdc.gov\/mmwr\/preview\/mmwrhtml\/mm5637a5.htm."},{"key":"10.1016\/j.vaccine.2017.10.065_b0100","unstructured":"World Health Organization. Immunization coverage [Internet]. 2016 [cited 2017 Mar 8]. Available from: http:\/\/www.who.int\/mediacentre\/factsheets\/fs378\/en\/."},{"key":"10.1016\/j.vaccine.2017.10.065_b0105","series-title":"The international encyclopedia of public health","first-page":"222","article-title":"Infectious disease surveillance","author":"Murray","year":"2017"},{"key":"10.1016\/j.vaccine.2017.10.065_b0110","doi-asserted-by":"crossref","unstructured":"Orenstein WA. The Role of Measles Elimination in Development of a National Immunization Program. Pediatr Infect Dis J [Internet]. 2006 Dec [cited 2017 Oct 14];25(12):1093\u2013101. Available from: http:\/\/content.wkhealth.com\/linkback\/openurl?sid=WKPTLP:landingpage&an=00006454-200612000-00002.","DOI":"10.1097\/01.inf.0000246840.13477.28"},{"issue":"5","key":"10.1016\/j.vaccine.2017.10.065_b0115","first-page":"546","article-title":"Effect of new procedures for immunization certificate inspections at kindergarten and school entry in Ningyang County of Shandong Province","volume":"22","author":"Yin","year":"2016","journal-title":"Chinese J Vaccine Immun"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X17314731?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X17314731?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,10,9]],"date-time":"2019-10-09T01:14:49Z","timestamp":1570583689000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X17314731"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,1]]},"references-count":23,"alternative-id":["S0264410X17314731"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2017.10.065","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2018,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Measles and Rubella Global Strategic Plan 2012\u20132020 midterm review report: Background and summary","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2017.10.065","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 World Health Organization; licensee Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}